10 PACK GLP-3R 10 mg

10 mg GLP-3R (10 Pack) is an experimental injectable peptide currently under clinical investigation. It is distinguished by its unique "triple agonist" mechanism, acting on three different hormone receptors to regulate metabolism.

Here is a summary of its primary attributes based on recent clinical research:

Triple Agonist Mechanism

Unlike existing treatments that target one or two receptors, retatrutide targets three:

• GLP-1 (Glucagon-like peptide-1): Enhances insulin secretion and slows gastric emptying to increase fullness.

• GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin sensitivity and lipid metabolism while reducing nausea often associated with GLP-1.

• GCGR (Glucagon receptor): Increases energy expenditure (calorie burning) and directly targets liver fat metabolism.

• Human trials have shown massive improvements in metabolic function, lipid profiles, and reduction in A1C glucose profiles, and fat reduction.